Optical imaging of the breast

被引:27
作者
de Ven, S. M. W. Y. van [1 ]
Elias, S. G. [1 ]
van den Bosch, M. A. A. J. [1 ]
Luijten, P. [1 ]
Mali, W. P. Th. M. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands
来源
CANCER IMAGING | 2008年 / 8卷 / 01期
关键词
Absorption; Breast cancer; Fluorescence; Molecular imaging; Optical imaging;
D O I
10.1102/1470-7330.2008.0032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This review provides a summary of the current state of optical breast imaging and describes its potential future clinical applications in breast cancer imaging. Optical breast imaging is a novel imaging technique that uses near-infrared light to assess the optical properties of breast tissue. In optical breast imaging, two techniques can be distinguished, i.e. optical imaging without contrast agent, which only makes use of intrinsic tissue contrast, and optical imaging with a contrast agent, which uses exogenous fluorescent probes. In this review the basic concepts of optical breast imaging are described, clinical studies on optical imaging without contrast agent are summarized, an outline of preclinical animal studies on optical breast imaging with contrast agents is provided, and, finally, potential applications of optical breast imaging in clinical practice are addressed. Based on the present literature, diagnostic performance of optical breast imaging without contrast agent is expected to be insufficient for clinical application. Development of contrast agents that target specific molecular changes associated with breast cancer formation is the opportunity for clinical success of optical breast imaging.
引用
收藏
页码:206 / 215
页数:10
相关论文
共 51 条
[41]  
Montet X., Ntziachristos V., Grimm J., Weissleder R., Tomographic fluorescence mapping of tumor targets, Cancer Research, 65, 14, pp. 6330-6336, (2005)
[42]  
Sampath L., Kwon S., Ke S., Wang W., Schiff R., Mawad M.E., Sevick-Muraca E.M., Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer, Journal of Nuclear Medicine, 48, 9, pp. 1501-1510, (2007)
[43]  
Yang M., Baranov E., Li X.-M., Wang J.W., Jiang P., Li N., Moossa A.R., Penman S., Hoffman R.M., Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors, Proceedings of the National Academy of Sciences of the United States of America, 98, 5, pp. 2616-2621, (2001)
[44]  
Wang W., Ke S., Kwon S., Yallampalli S., Cameron A.G., Adams K.E., Mawad M.E., Sevick-Muraca E.M., A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain, Bioconjugate Chemistry, 18, 2, pp. 397-402, (2007)
[45]  
Yang Z., Zheng S., Harrison W.J., Harder J., Wen X., Gelovani J.G., Qiao A., Li C., Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: Synthesis, characterization, and dual nuclear/optical imaging, Biomacromolecules, 8, 11, pp. 3422-3428, (2007)
[46]  
Intes X., Ripoll J., Chen Y., Nioka S., Yodh A.G., Chance B., In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green, Medical Physics, 30, 6, pp. 1039-1047, (2003)
[47]  
Ntziachristos V., Yodh A.G., Schnall M., Chance B., Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement, Proceedings of the National Academy of Sciences of the United States of America, 97, 6, pp. 2767-2772, (2000)
[48]  
Lehman C.D., Isaacs C., Schnall M.D., Pisano E.D., Ascher S.M., Weatherall P.T., Bluemke D.A., Bowen D.J., Marcom P.K., Armstrong D.K., Domchek S.M., Tomlinson G., Skates S.J., Gatsonis C., Cancer yield of mammography, MR, and US in high-risk women: Prospective multi-institution breast cancer screening study, Radiology, 244, 2, pp. 381-388, (2007)
[49]  
Lehman C.D., Gatsonis C., Kuhl C.K., Hendrick R.E., Pisano E.D., Hanna L., Peacock S., Smazal S.F., Maki D.D., Julian T.B., DePeri E.R., Bluemke D.A., Schnall M.D., MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer, New England Journal of Medicine, 356, 13, pp. 1295-1303, (2007)
[50]  
Liberman L., Mason G., Morris E.A., Dershaw D.D., Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size, American Journal of Roentgenology, 186, 2, pp. 426-430, (2006)